5 Ways to Avoid the 'Yes Trap' in Clinical Trials

Feasibility Excellence: Superior Capability

Category: TrialMatch Platform Target Audience: Research Directors Reading Time: 6 minutes

As a Research Director, you are under constant pressure to say "yes."

"Can you enroll 20 patients in 3 months?" Yes. "Do you have access to this specific biomarker population?" Yes. "Can you start up in 4 weeks?" Yes.

You say yes because you want the study. You say yes because you believe in your team. But too often, that "yes" is based on a guess, not data. And when the study starts and the patients don't materialize, that "yes" turns into a liability.

This is the "Yes Trap." It damages your reputation with sponsors, burns out your coordinators, and ultimately hurts your bottom line.

Feasibility Excellence is about escaping the trap. It's about having the superior capability to know—with certainty—what your site can deliver, and proving it to sponsors before the contract is even signed.

Most sites complete feasibility questionnaires based on "gut feel" or outdated EMR queries.

The Problem: EMR data is often unstructured and incomplete. A patient might be coded for "diabetes," but the EMR won't tell you if they meet the specific HbA1c inclusion criteria for the trial. The Result: You overestimate your pool. You promise 20 patients, but only 5 actually qualify. The Impact: Sponsors lose trust. They stop inviting you to future trials. Your "site score" in their database drops.

In a competitive market, sponsors are looking for sites that deliver predictable performance. They don't want a hopeful "yes"; they want a data-backed promise.

Stop relying on cold EMR queries. You need a "warm" database of patients who are pre-screened and engaged.

Actionable Insight: Implement a continuous engagement strategy. Don't just contact patients when you have a study. Keep them warm with newsletters, health tips, and check-ins. When a new study opens, you shouldn't be starting from scratch; you should be activating a waiting list.

Instead of guessing, use advanced analytics to query your patient population against the exact protocol criteria. If the protocol requires a specific medication history, your query should filter for that.

Actionable Insight: Invest in tools that can parse unstructured notes in your EMR. Natural Language Processing (NLP) can find patients who match complex criteria that standard ICD-10 codes miss. This gives you a true count of eligible patients, not just a rough estimate.

Don't wait for sponsors to ask you. Tell them what you can do.

Top-performing sites practice "Reverse Feasibility." They analyze their own patient data, identify high-potential populations, and then proactively approach sponsors who have drugs in that pipeline.

Actionable Insight: "We have 50 patients with Condition X who have failed first-line therapy and are looking for options. Do you have a trial for them?" This flips the script. You aren't begging for a study; you are offering a solution.

How TheraNovex Delivers Feasibility Excellence

At TheraNovex, we built the TrialMatch Platform to give Research Directors a superpower: certainty.

The "Deep Match" Engine TrialMatch doesn't just look at diagnosis codes. Our AI analyzes the full clinical picture—labs, meds, history, and notes—to match patients to protocols with 95% accuracy. When you fill out a feasibility questionnaire using TrialMatch data, you aren't guessing. You are stating facts.

The Verified Patient Pool We don't just give you numbers; we give you names. Our platform identifies specific, reachable patients who match the criteria right now . You can show the sponsor: "I don't just think I can enroll 10 patients; here are the 15 candidates we have ready to screen tomorrow."

The Sponsor Trust Score Sites that use TheraNovex consistently hit their enrollment targets. This builds your "Trust Score" with sponsors. When they see a feasibility assessment backed by TheraNovex data, they know it's real. They prioritize your site for selection because you represent low risk and high reliability.

Conclusion: The Power of "No" (and the Better "Yes")

Feasibility Excellence sometimes means saying "no" to the wrong study so you can say a confident "yes" to the right one.

By using data to drive your decisions, you protect your site's reputation and profitability. You become a strategic partner to sponsors, not just a vendor. You stop chasing impossible targets and start delivering superior results.

Ready to upgrade your capability? Learn how TheraNovex helps Research Directors achieve Feasibility Excellence.